{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:48:46Z","timestamp":1790124526775,"version":"4.0.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.juro.2014.11.057","type":"journal-article","created":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T13:00:21Z","timestamp":1416229221000},"page":"1245-1251","source":"Crossref","is-referenced-by-count":30,"title":["Classic and Nonclassic HLA Class I Expression in Penile Cancer and Relation to HPV Status and Clinical Outcome"],"prefix":"10.1097","volume":"193","author":[{"given":"Rosa S.","family":"Djajadiningrat","sequence":"first","affiliation":[{"name":"Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Horenblas","sequence":"additional","affiliation":[{"name":"Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00eblle A.M.","family":"Heideman","sequence":"additional","affiliation":[{"name":"Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Sanders","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"de Jong","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina S.","family":"Jordanova","sequence":"additional","affiliation":[{"name":"Centre for Gynaecologic Oncology Amsterdam, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2014.11.057_bib1","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1172\/JCI31405","article-title":"Immune surveillance of tumors","volume":"117","author":"Swann","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.juro.2014.11.057_bib2","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.1038\/onc.2008.273","article-title":"HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance","volume":"27","author":"Campoli","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.juro.2014.11.057_bib3","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/ni1102-999","article-title":"Natural selection of tumor variants in the generation of tumor escape phenotypes","volume":"3","author":"Khong","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.juro.2014.11.057_bib4","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.semcancer.2012.03.003","article-title":"The role of classical and non-classical HLA class I antigens in human tumors","volume":"22","author":"Bukur","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.juro.2014.11.057_bib5","doi-asserted-by":"crossref","first-page":"e26491","DOI":"10.4161\/onci.26491","article-title":"Role of non-classical MHC class I molecules in cancer immunosuppression","volume":"2","author":"Kochan","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.juro.2014.11.057_bib6","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00262-010-0893-2","article-title":"The\u00a0escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible \u201chard\u201d lesions","volume":"59","author":"Garrido","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.juro.2014.11.057_bib7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00005-011-0137-y","article-title":"Clinical significance of the HLA-E and CD94\/NKG2 interaction","volume":"59","author":"Iwaszko","year":"2011","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.juro.2014.11.057_bib8","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1158\/1078-0432.CCR-13-0731","article-title":"New strategies in lung cancer: translating immunotherapy into clinical practice","volume":"20","author":"Forde","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.juro.2014.11.057_bib9","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1158\/1078-0432.CCR-13-2151","article-title":"The intersection of immune-directed and molecularly targeted therapy in advanced melanoma: where we have been, are, and will be","volume":"19","author":"Sullivan","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.juro.2014.11.057_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00345-008-0302-z","article-title":"Penile cancer: epidemiology, pathogenesis and prevention","volume":"27","author":"Bleeker","year":"2009","journal-title":"World J Urol"},{"key":"10.1016\/j.juro.2014.11.057_bib11","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.juro.2014.08.087","article-title":"Human papillomavirus prevalence in invasive penile cancer and association with clinical outcome","volume":"193","author":"Djajadiningrat","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2014.11.057_bib12","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.oraloncology.2012.06.019","article-title":"Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis","volume":"48","author":"O\u2019Rorke","year":"2012","journal-title":"Oral Oncol"},{"key":"10.1016\/j.juro.2014.11.057_bib13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ijc.27635","article-title":"MHC class I expression in HPV positive and negative tonsillar squamous cell carcinoma in correlation to clinical outcome","volume":"132","author":"N\u00e4sman","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.juro.2014.11.057_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00262-007-0362-8","article-title":"Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma","volume":"57","author":"Mehta","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.juro.2014.11.057_bib15","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.humimm.2005.10.011","article-title":"Frequent HLA class I loss is an early event\u00a0in cervical carcinogenesis","volume":"66","author":"Vermeulen","year":"2005","journal-title":"Hum Immunol"},{"key":"10.1016\/j.juro.2014.11.057_bib16","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S0959-8049(98)00151-8","article-title":"Quality control of immunohistochemical evaluation of tumour-associated plasminogen activators and related components","volume":"34","author":"Ruiter","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.juro.2014.11.057_bib17","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1158\/1078-0432.CCR-07-4554","article-title":"Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+\/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?","volume":"14","author":"Jordanova","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.juro.2014.11.057_bib18","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1038\/bjc.2014.549","article-title":"Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients","volume":"111","author":"Zeestraten","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.juro.2014.11.057_bib19","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/jcp.10290","article-title":"MHC class I antigens, immune surveillance, and tumor immune escape","volume":"195","author":"Garcia-Lora","year":"2003","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.juro.2014.11.057_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2014.00105","article-title":"TLR\/NCR\/KIR: which one to use and when?","volume":"5","author":"Sivori","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.juro.2014.11.057_bib21","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1593\/neo.101684","article-title":"Human leukocyte antigen E contributes to protect tumor cells from lysis by natural killer cells","volume":"13","author":"Lo Monaco","year":"2011","journal-title":"Neoplasia"},{"key":"10.1016\/j.juro.2014.11.057_bib22","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.4049\/jimmunol.1002629","article-title":"HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients","volume":"185","author":"De Kruijf","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.juro.2014.11.057_bib23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1479-5876-10-184","article-title":"HLA-E expression in cervical adenocarcinomas: association with improved long-term survival","volume":"10","author":"Spaans","year":"2012","journal-title":"J Transl Med"},{"key":"10.1016\/j.juro.2014.11.057_bib24","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1158\/0008-5472.CAN-04-2108","article-title":"Up-regulation of inhibitory natural killer receptors CD94 \/ NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8 + T lymphocytes in human cervical carcinoma","volume":"65","author":"Sheu","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2014.11.057_bib25","doi-asserted-by":"crossref","first-page":"10556","DOI":"10.1073\/pnas.1100354108","article-title":"HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8(+) T lymphocytes","volume":"108","author":"Gooden","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.juro.2014.11.057_bib26","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1177\/1933719110369183","article-title":"Human leukocyte antigen-G (HLA-G) expression in cervical lesions: association with cancer progression, HPV 16\/18 infection, and host immune response","volume":"17","author":"Dong","year":"2010","journal-title":"Reprod Sci"},{"key":"10.1016\/j.juro.2014.11.057_bib27","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1158\/0008-5472.CAN-07-2704","article-title":"Human leukocyte antigen-G and cancer immunoediting","volume":"68","author":"Urosevic","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2014.11.057_bib28","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1038\/sj.onc.1210798","article-title":"High-risk human papillomavirus E7 expression reduces cell-surface MHC class I molecules and increases susceptibility to natural killer cells","volume":"27","author":"Bottley","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.juro.2014.11.057_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/gm453","article-title":"Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies\u00a0novel genetic alterations in HPV+ and HPV\u2212 tumors","volume":"5","author":"Lechner","year":"2013","journal-title":"Genome Med"},{"key":"10.1016\/j.juro.2014.11.057_bib30","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1158\/2326-6066.CIR-13-0097","article-title":"Immune-escape markers in relation to clinical outcome of advanced melanoma patients following immunotherapy","volume":"2","author":"Tjin","year":"2014","journal-title":"Cancer Immunol Res"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534714049039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534714049039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2014.11.057","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T03:57:49Z","timestamp":1651204669000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2014.11.057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["10.1016\/j.juro.2014.11.057"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2014.11.057","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}